Colgate-palmolive Company ((CL)) has held its Q4 earnings call. Read on for the main highlights of the call.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Colgate-Palmolive’s latest earnings call blended optimism with caution as executives celebrated record cash generation, broad-based emerging market gains, and renewed Q4 momentum while underscoring the reality of low category growth, U.S. softness, and cost volatility that could blur the near-term picture.
Delivered Growth Across Key Financial Metrics in 2025
Colgate capped 2025 by expanding organic and net sales, gross profit, base-business EPS, and free cash flow, completing a strategic plan that added $5 billion in revenue despite macro and category headwinds.
Q4 Momentum — Organic Growth and Sequential Improvement
Fourth-quarter underlying organic sales exceeded 3% when stripping out the planned private-label exit, with every division but North America improving sequentially and all four categories producing positive organic growth.
Strong Hill’s Performance
Hill’s Pet Nutrition remained a standout, posting more than 5% growth excluding private label, roughly 2% underlying volume gains, and share advances in prescription diet and therapeutic segments, reinforcing its role as a structural profit engine.
Emerging Markets Strength
Emerging markets grew about 4.5% organically, with Mexico and Brazil delivering high-single-digit gains and Asia/Africa improving, offsetting sluggish developed-market categories.
Record Operating Cash Flow and Strong Balance Sheet
A record $4.2 billion in operating cash flow, higher free cash conversion, and low leverage fortified balance sheet flexibility for reinvestment, dividends, buybacks, and targeted M&A.
Prime 100 Acquisition Performing Ahead of Plan
The Prime 100 fresh pet food acquisition exceeded expectations, and management is testing how its learnings can enhance broader pet nutrition offerings.
Investment in Capabilities and Advertising Efficiency
Management accelerated spend on omnichannel, revenue growth management, digital, data/AI, and supply chain; while A&P dollars climbed about 5%, ratio-to-sales edged lower thanks to sharper targeting and measurement.
Low and Volatile Category Growth
Category growth has stabilized around 1.5%–2.5%, well below historical averages, prompting a cautious stance and wide 2026 organic sales guidance to reflect uncertain consumer demand.
Cost Pressures — Raw Materials and Tariffs
Unexpected raw material inflation and higher tariffs constrained margins, forcing pricing and productivity actions to shoulder more of the profitability burden.
North America Underperformance and Category Weakness
North America failed to keep pace with the rest of the portfolio as U.S. categories saw repeated monthly volume declines, especially in Home Care and fabric softeners, leaving the division without the sequential lift seen elsewhere.
Promotional Pressure and Pantry Destocking
Rising promotions, couponing, and pantry destocking are suppressing volumes and could squeeze margins if competitive intensity escalates further.
Private-Label Impact and Planned Exit
The private-label business carved roughly 360 basis points off volumes, and Colgate’s planned exit is skewing comps near term but should enhance mix over time.
Foreign Exchange Volatility Risk
FX delivered a modest Q4 tailwind and may offer a low-single-digit revenue lift in early 2026, yet management reminded investors that currency has been unfavorable in eight of the past 10 years, necessitating hedged expectations.
Impairment and Market-Driven Adjustments
A fresh impairment highlighted the need to recalibrate assets amid shifting consumer dynamics, underscoring management’s willingness to fine-tune the portfolio.
Guidance and Outlook
Colgate forecast 2026 net and organic sales growth of 1%–4%, tethered to category trajectories: sluggish demand keeps results near the bottom, current rates anchor the midpoint, and stronger categories unlock the top end; FX is expected to help early in the year, with benefits split between reinvestment and margins, supplemented by SGPP, RGM, and productivity gains.
Colgate heads into 2026 with sturdy cash generation, pet and emerging market tailwinds, and meaningful capability investments, yet the company is bracing for a choppy macro landscape marked by flat categories, promotional intensity, and FX uncertainty—making disciplined execution the central theme to watch.